Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDC25B | P30305 | 2/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.67 |
| ▸ | TP53 | P04637 | 1/20 | 0.67 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.67 |
| ▸ | HPGD | P15428 | 1/20 | 0.67 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.67 |
| ▸ | TSHR | P16473 | 1/20 | 0.67 |
| ▸ | ATM | Q13315 | 1/20 | 0.67 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.67 |
| ▸ | FADS1 | O60427 | 1/20 | 0.65 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.58 |
| ▸ | RAB9A | P51151 | 2/20 | 0.54 |
| ▸ | NPC1 | O15118 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 3/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.52 |
| ▸ | GAA | P10253 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | GLA | P06280 | 1/20 | 0.52 |
| ▸ | RECQL | P46063 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30074722 | 1.00 | CDC25B (0.67) | CDC25BALDH1A1TP53CYP3A4HPGD | |
| SCHEMBL11587472 | 0.87 | CDC25B (0.63) | CDC25BALDH1A1TP53CYP3A4HPGD | |
| SCHEMBL29458805 | 0.87 | NPSR1 (0.51) | CDC25BALDH1A1TP53CYP3A4HPGD | |
| SCHEMBL28226651 | 0.87 | NPSR1 (0.51) | CDC25BALDH1A1TP53CYP3A4HPGD | |
| SCHEMBL10338322 | 0.87 | CDC25B (0.80) | CDC25BALDH1A1TP53CYP3A4HPGD | |
| SCHEMBL28613252 | 0.86 | NPSR1 (0.55) | CDC25BALDH1A1TP53CYP3A4HPGD | |
| SCHEMBL1922073 | 0.85 | NPSR1 (0.72) | ALDH1A1CYP3A4HSD17B10NPSR1MAPT | |
| SCHEMBL7527181 | 0.83 | NPSR1 (0.64) | CYP3A4NPSR1MAPTTDP1CCR4 | |
| SCHEMBL21525100 | 0.82 | CDC25B (0.67) | CDC25BALDH1A1TP53CYP3A4HPGD | |
| SCHEMBL30575369 | 0.81 | CDC25B (0.71) | CDC25BALDH1A1TP53CYP3A4HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11502261-B2 | Compound and organic light emitting device using the same | LG CHEM LTD. (KR) | 2022-11-15 | — | — | US | disclosed |
| EP-3564249-B1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME | LG CHEMICAL LTD (KR) | 2021-01-20 | — | — | EP | disclosed |
| EP-3564249-B1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME | LG CHEMICAL LTD (KR) | 2021-01-20 | — | — | EP | disclosed |
| CN-107778309-B | Quinoline derivative and application thereof | 北京鼎材科技有限公司 | 2020-10-16 | — | — | CN | disclosed |
| US-20200058885-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | LG CHEM, LTD. (KR) | 2020-02-20 | — | — | US | disclosed |
| US-20200058885-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | LG CHEM, LTD. (KR) | 2020-02-20 | — | — | US | disclosed |
| EP-3564249-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME | LG Chem, Ltd. (KR) | 2019-11-06 | — | — | EP | disclosed |
| EP-3564249-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME | LG Chem, Ltd. (KR) | 2019-11-06 | — | — | EP | disclosed |
| US-20180079984-A1 | ALKYLATED ALKOXYDIARYLAMINE ANTIOXIDANTS | LANXESS CORPORATION | 2018-03-22 | — | — | US | disclosed |
| CN-107778309-A | A kind of and quinoline and its application | 北京鼎材科技有限公司 | 2018-03-09 | — | — | CN | disclosed |
| WO-2005090512-A1 | NEW MATERIALS FOR INJECTING OR TRANSPORTING HOLES AND ORGANIC ELECTROLUMINESCENCE DEVICES USING THE SAME | LG CHEM, LTD. (KR) | 2005-09-29 | — | — | WO | disclosed |
| US-6861162-B2 | Doped thin films; multilayer; electrolytic cells; light emitting diodes | CITYU RESEARCH LTD. (CN) | 2005-03-01 | — | — | US | disclosed |
| US-6833202-B2 | Luminescent layer uses as salicylaldiminato Schiff bases or their metal complexes based on diaminomaleonitrile and salicylaldehyde derivatives as red-emitting materials; color chromaticity | CITY UNIVERSITY OF HONG KONG (CN) | 2004-12-21 | — | — | US | disclosed |
| US-20040180234-A1 | Electroluminescent devices | HONG KONG, CITY UNIVERSITY OF (CN) | 2004-09-16 | — | — | US | disclosed |
| US-20040049080-A1 | Novel triphenylamines and use thereof | SHIROTA, YASUHIKO (JP) | 2004-03-11 | — | — | US | disclosed |
| US-20040043247-A1 | Organic electroluminescence devices using pyrazolo [3,4B] quinoxaline derivatives | INTELLECTUAL VENTURES HOLDING 57 LLC | 2004-03-04 | — | — | US | disclosed |
| EP-1300390-A1 | NOVEL TRIPHENYLAMINES AND USE THEREOF | BANDO CHEMICAL INDUSTRIES, LTD. (JP) | 2003-04-09 | — | — | EP | disclosed |
| EP-0167820-B1 | PROCESS FOR THE PREPARATION OF OPTIONALLY SUBSTITUTED BENZ(C,D)-INDOL-2-ONES (NAPHTHOLACTAMES) | BAYER AG (DE) | 1989-04-26 | — | — | EP | disclosed |
| EP-0167820-A2 | Process for the preparation of optionally substituted benz(c,d)-indol-2-ones (naphtholactames) | BAYER AG (DE) | 1986-01-15 | — | — | EP | disclosed |
| US-4067903-A | Manufacture of arylamines | BASF AKTIENGESELLSCHAFT (DT) | 1978-01-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040180234-A1 | Electroluminescent devices | SLC25A13, AOC1, DDT | CDC25B 3157/4885ALDH1A1 37/4885TP53 3162/4885 |
| US-11502261-B2 | Compound and organic light emitting device using the same | TRPA1, CRY1, TMEM109 | CDC25B 2052/4885ALDH1A1 27/4885TP53 3995/4885 |
| US-20040049080-A1 | Novel triphenylamines and use thereof | NAT1, TPR, PNMT | CDC25B 301/4885ALDH1A1 1300/4885TP53 566/4885 |
| US-20200058885-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | TMEM109, CRY1, TRPA1 | CDC25B 2077/4885ALDH1A1 28/4885TP53 4544/4885 |
| US-20180079984-A1 | ALKYLATED ALKOXYDIARYLAMINE ANTIOXIDANTS | GPX4, CAT, SOD1 | CDC25B 2735/4885ALDH1A1 50/4885TP53 2452/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.